We are live on ! Find out more
KRRO icon

Korro Bio

71 hedge funds and large institutions have $285M invested in Korro Bio in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

11% more funds holding

Funds holding: 6471 (+7)

0.79% more ownership

Funds ownership: 91%91.8% (+0.79%)

0% less capital invested

Capital invested by funds: $286M → $285M (-$416K)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
71
Holders Change
+7
Holders Change %
+10.94%
% of All Funds
1.02%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
15
Increased
22
Reduced
14
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LCM
76
Lynx1 Capital Management
Puerto Rico
-$129K -3,800 Closed
SIS
77
Strategic Investment Solutions
Illinois
-$95 -10 Closed
KFS
78
Kelly Financial Services
Massachusetts
-$34 -1 Closed
Carson Wealth (CWM LLC)
79
Carson Wealth (CWM LLC)
Nebraska
+$126 +3 New

KRRO Hedge Fund Activity: Q3 2024 in Review

71 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2024, worth a combined $285M — down 0.15% from $286M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new KRRO positions and 8 closed out — a net gain of 7 holders — while 22 added to existing stakes and 14 trimmed.

The largest buyer was Schonfeld Strategic Advisors, adding an estimated $4.31M. The largest seller was Artal Group, exiting entirely with an estimated $14M sold.

  • 71 institutional investors held Korro Bio (KRRO) as of Q3 2024, up from 64 in Q2 2024.
  • Funds reported $285M of Korro Bio stock for Q3 2024, down 0.15% quarter-over-quarter.
  • 15 funds opened new Korro Bio positions in Q3 2024 and 8 closed out, a net change of +7 holders.
  • The largest Korro Bio buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $4.31M added.
  • The largest Korro Bio seller in Q3 2024 was Artal Group, an estimated $14M sold.

Based on aggregated 13F filings for Q3 2024.